{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:08:35Z","timestamp":1794478115845,"version":"4.9.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1053\/j.gastro.2023.10.016","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T23:42:16Z","timestamp":1700264536000},"page":"202-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review"],"prefix":"10.1053","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-8216","authenticated-orcid":false,"given":"Guadalupe","family":"Garcia-Tsao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan G.","family":"Abraldes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Wai-Sun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2023.10.016_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib2","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2023.10.016_bib3","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the burden of chronic liver disease among hospitalized US adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.gastro.2023.10.016_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis\u2014aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib6","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.cgh.2023.03.019","article-title":"Update in the treatment of the complications of cirrhosis","volume":"21","author":"Abraldes","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib10","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1097\/MEG.0000000000002282","article-title":"Outcomes of early versus delayed endoscopy in cirrhotic patients with acute variceal bleeding: a systematic review with meta-analysis","volume":"33","author":"Bai","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2005.41381.x","article-title":"Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison","volume":"100","author":"Baik","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.10.016_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1055\/a-1939-4887","article-title":"Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"54","author":"Gralnek","year":"2022","journal-title":"Endoscopy"},{"key":"10.1053\/j.gastro.2023.10.016_bib14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-2036.2012.05088.x","article-title":"Meta-analysis: vasoactive medications for the management of acute variceal bleeds","volume":"35","author":"Wells","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2023.10.016_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013437","article-title":"Terlipressin for the treatment of acute variceal bleeding: a systematic review and meta-analysis of randomized controlled trials","volume":"97","author":"Zhou","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.gastro.2023.10.016_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MEG.0000000000000300","article-title":"Comparison of 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: a randomized clinical study","volume":"27","author":"Rengasamy","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib17","first-page":"334","article-title":"Comparison of 12-hour with 72-hour terlipressin therapy for bleeding esophageal varices","volume":"27","author":"Salim","year":"2017","journal-title":"J\u00a0Coll Physicians Surg Pak"},{"key":"10.1053\/j.gastro.2023.10.016_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/s0004-2803.202200001-16","article-title":"Rational for continuing terlipressin after endoscopic variceal ligation in acute variceal haemorrhage needs further evidence: a pilot study","volume":"59","author":"Poudel","year":"2022","journal-title":"Arq Gastroenterol"},{"key":"10.1053\/j.gastro.2023.10.016_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.15403\/jgld-3191","article-title":"Vasoactive agents for the management of acute variceal bleeding: a systematic review and meta-analysis","volume":"30","author":"Huaringa-Marcelo","year":"2021","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"key":"10.1053\/j.gastro.2023.10.016_bib20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1572-0241.2004.40665.x","article-title":"Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose","volume":"100","author":"Villanueva","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.10.016_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12072-022-10416-6","article-title":"Low-dose continuous terlipressin infusion is effective and safer than intravenous bolus injections in reducing portal pressure and control of acute variceal bleeding","volume":"17","author":"Arora","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2023.10.016_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12664-018-0871-8","article-title":"Comparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: an open-label randomized controlled trial","volume":"37","author":"Jha","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.10.016_bib23","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1530\/EJE-19-0074","article-title":"Anniversary review: octreotide, 40 years later","volume":"181","author":"Lamberts","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.gastro.2023.10.016_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/hep.1840050310","article-title":"The effect of large volume paracentesis on plasma volume\u2014a cause of hypovolemia?","volume":"5","author":"Kao","year":"1985","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib25","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.10.016_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis","volume":"113","author":"Ruiz-del-Arbol","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.10.016_bib27","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gin\u00e8s","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.10.016_bib28","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.gastro.2023.10.016_bib29","first-page":"CD004039","article-title":"Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis","volume":"6","author":"Simonetti","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2023.10.016_bib30","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib31","first-page":"881","article-title":"Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study","volume":"43","author":"Alessandria","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2023.10.016_bib32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.31071","article-title":"Paracentesis-induced circulatory dysfunction with modest-volume paracentesis is partly ameliorated by albumin infusion in acute-on-chronic liver failure","volume":"72","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib33","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2004.05.009","article-title":"Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"41","author":"Fern\u00e1ndez","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2023.10.016_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib37","article-title":"Efficacy of intravenous albumin for spontaneous bacterial peritonitis infection among patients with cirrhosis: a meta-analysis of randomized control trials","volume":"14","author":"Batool","year":"2022","journal-title":"Cureus"},{"key":"10.1053\/j.gastro.2023.10.016_bib38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A\u00a0randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fernandez","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MEG.0000000000000635","article-title":"Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis","volume":"28","author":"Salman","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365520902719273","article-title":"Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"44","author":"Chen","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.10.016_bib41","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/gutjnl-2011-301739","article-title":"Low-dose albumin in the treatment of spontaneous bacterial peritonitis: should we change the standard treatment?","volume":"61","author":"de Araujo","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.10.016_bib42","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib43","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial","volume":"62","author":"Th\u00e9venot","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib44","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cgh.2019.07.055","article-title":"Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis","volume":"18","author":"Fern\u00e1ndez","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib45","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.dld.2020.05.047","article-title":"Efficacy and safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: a systematic review and meta-analysis","volume":"52","author":"Wong","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2023.10.016_bib46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib47","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0140-6736(62)90895-4","article-title":"The effect of repeated albumin infusions in patients with cirrhosis","volume":"2","author":"Wilkinson","year":"1962","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2023.10.016_bib48","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1681\/ASN.V1251010","article-title":"Effects of albumin\/furosemide mixtures on responses to furosemide in hypoalbuminemic patients","volume":"12","author":"Chalasani","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2023.10.016_bib49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(99)80194-9","article-title":"Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial","volume":"30","author":"Gentilini","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib50","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.10.016_bib51","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2023.10.016_bib52","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib53","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A\u00a0randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2023.10.016_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhep.2006.09.012","article-title":"Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites","volume":"46","author":"Kalambokis","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib55","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2036.2010.04426.x","article-title":"The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites","volume":"32","author":"Misra","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2023.10.016_bib56","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cgh.2012.06.027","article-title":"The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis","volume":"10","author":"Bari","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib57","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.cgh.2022.08.033","article-title":"AGA Clinical Practice Update on the evaluation and management of acute kidney injury in patients with cirrhosis: expert review","volume":"20","author":"Flamm","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.10.016_bib58","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0016-5085(79)90153-7","article-title":"Studies on the renin-angiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion","volume":"77","author":"Wong","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.10.016_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.10.016_bib60","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/apt.17195","article-title":"Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure","volume":"56","author":"Wong","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2023.10.016_bib61","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000501299","article-title":"Point-of-care echocardiography unveils misclassification of acute kidney injury as hepatorenal syndrome","volume":"50","author":"Velez","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.gastro.2023.10.016_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1053\/j.gastro.2023.10.016_bib63","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000359","article-title":"Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study","volume":"12","author":"Allegretti","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2023.10.016_bib64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib65","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/hep.32799","article-title":"Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury","volume":"77","author":"Gambino","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib66","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/hep.32807","article-title":"NGAL in AKI and cirrhosis\u2014Ready for prime time?","volume":"77","author":"Allegretti","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib67","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.10.016_bib68","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2023.10.016_bib69","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1097\/01.HC9.0000897228.91307.0c","article-title":"Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies","volume":"7","author":"Curry","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2023.10.016_bib70","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.10.016_bib71","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.10.016_bib72","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.10.016_bib73","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.30208","article-title":"Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","volume":"71","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib74","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/CCM.0000000000005595","article-title":"The comparative effectiveness of vasoactive treatments for hepatorenal syndrome: a systematic review and network meta-analysis","volume":"50","author":"Pitre","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1053\/j.gastro.2023.10.016_bib75","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra2215289","article-title":"Acute kidney injury in patients with cirrhosis","volume":"388","author":"Nadim","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2023.10.016_bib77","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.10.016_bib78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fern\u00e1ndez","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.10.016_bib79","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000476","article-title":"Targeted albumin infusions do not improve systemic inflammation or cardiovascular function in decompensated cirrhosis","volume":"13","author":"China","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2023.10.016_bib80","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508523051430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508523051430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:41:45Z","timestamp":1758037305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508523051430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0016508523051430"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2023.10.016","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2023.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}